The potential use of bacteria and their derivatives as delivery systems for nanoparticles in the treatment of cancer
Shiva Ahmadishoar,
No information about this author
Saba Saeed,
No information about this author
Morug Salih Mahdi
No information about this author
et al.
Journal of drug targeting,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 54
Published: April 5, 2025
Cancer
is
a
leading
cause
of
mortality
and
morbidity
worldwide.
Nanomaterials,
unique
optical,
magnetic,
electrical
properties
at
the
nanoscale
(1-100
nm),
have
been
engineered
to
improve
drug
capacity,
bioavailability,
specificity
in
cancer
treatment.
These
advancements
address
toxicity
lack
selectivity
conventional
therapies,
enabling
precise
targeting
cells,
tumor
microenvironment,
immune
system.
Among
emerging
approaches,
bacterial
treatment
shows
promise
due
its
natural
ability
target
diverse
therapeutic
mechanisms,
which
nanotechnology
can
further
enhance.
Bacteria-based
delivery
systems
leverage
bacteria's
adaptability
survival
strategies
within
human
body.
Bacterial
derivatives,
such
as
ghosts
(BGs),
extracellular
vesicles
(BEVs),
dietary
toxins,
are
recognized
effective
biological
nanomaterials
capable
carrying
nanoparticles
(NPs).
attracted
increasing
attention
for
their
potential
targeted
NP
This
study
explores
use
various
bacteria
byproducts
vehicles,
highlighting
treating
different
types
cancer.
By
combining
strengths
therapy,
these
innovative
approaches
aim
revolutionize
with
improved
precision
efficacy.
Language: Английский
Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
Xiaodan Wan,
No information about this author
Xueliang Zhou,
No information about this author
Jinlong Liu
No information about this author
et al.
Bioengineering & Translational Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 16, 2025
Abstract
Non‐small
cell
lung
cancer
(NSCLC)
presents
significant
therapeutic
challenges,
often
characterized
by
aggressive
proliferation
and
metastasis.
This
study
investigates
the
role
of
SLC7A11,
a
ferroptosis‐related
gene,
in
NSCLC
progression
potential
engineered
bacterial
extracellular
vesicles
(BEVs)
expressing
SLC7A11‐targeting
siRNA
as
strategy.
Using
TCGA
GEO
databases,
we
identified
that
SLC7A11
was
significantly
upregulated
tissues.
Functional
assays
demonstrated
knockdown
lines
(NCI‐H2122
NCI‐H647)
via
qPCR,
Western
blot,
immunofluorescence
resulted
impaired
proliferation,
migration,
invasion
abilities.
In
vivo
xenograft
models
further
revealed
inhibited
tumor
growth
metastasis,
corroborated
histological
analyses.
To
enhance
targeted
delivery
siRNA,
BEVs
with
targeting
peptide,
verifying
their
structure
function
through
transmission
electron
microscopy
(TEM)
nanoparticle
tracking
analysis
(NTA).
toxicity
assessments
indicated
safety
for
these
bioengineered
vesicles.
Importantly,
treatment
BEVs‐LCTP‐siSLC7A11
not
only
tumorigenesis
but
also
activated
ferroptosis
pathways,
evidenced
altered
expression
levels
transferrin
metastatic
Our
findings
suggest
promising
approach
to
inhibit
while
activating
ferroptosis,
offering
insights
into
novel
strategies
against
cancer.
Language: Английский
Exosome-Integrated Hydrogels for Bone Tissue Engineering
Hee Sook Hwang,
No information about this author
Chung‐Sung Lee
No information about this author
Gels,
Journal Year:
2024,
Volume and Issue:
10(12), P. 762 - 762
Published: Nov. 23, 2024
Exosome-integrated
hydrogels
represent
a
promising
frontier
in
bone
tissue
engineering,
leveraging
the
unique
biological
properties
of
exosomes
to
enhance
regenerative
capabilities
hydrogels.
Exosomes,
as
naturally
occurring
extracellular
vesicles,
carry
diverse
array
bioactive
molecules
that
play
critical
roles
intercellular
communication
and
regeneration.
When
combined
with
hydrogels,
these
can
be
spatiotemporally
delivered
target
sites,
offering
controlled
sustained
release
therapeutic
agents.
This
review
aims
provide
comprehensive
overview
recent
advancements
development,
application
exosome-integrated
for
highlighting
their
potential
overcome
current
challenges
Furthermore,
explores
mechanistic
pathways
by
which
embedded
within
facilitate
repair,
encompassing
regulation
inflammatory
pathways,
enhancement
angiogenic
processes,
induction
osteogenic
differentiation.
Finally,
addresses
existing
challenges,
such
scalability,
reproducibility,
regulatory
considerations,
while
also
suggesting
future
directions
research
this
rapidly
evolving
field.
Thus,
we
hope
contributes
advancing
development
next-generation
biomaterials
synergistically
integrate
exosome
hydrogel
technologies,
thereby
enhancing
efficacy
Language: Английский